Round robin trial
NordiQC Run 55 2019 „CK5“
Cytokeratin 5 & 14, Clone XM26 + LL002 (MSK106) – Assessment Results.
NordiQC Run 56 2019 „Melan A (MLA)“
MART-1 (Melan-A), Clone M2-7C10 (MSK056) – Assessment Results.
NordiQC Run C5 2019 „PD-L1 (uro)“
Focused on the accuracy of PD-L1 IHC assays in order to identify patients with urothelial carcinomas to be treated with Pembrolizumab as immune therapy, PD-L1, Clone CAL10 (RBK063) – Assessment Results.
NordiQC Run C5 2019 „PD-L1 (lung)“
Focused on the accuracy of PD-L1 IHC assays in order to identify patients with non-small cell lung carcinoma (NSCLC) benefitting from immune therapy with Pembrolizumab, PD-L1, Clone CAL10 (RBK063) – Assessment Results.
back to Certificates
